Stay updated on Canakinumab with Docetaxel in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Canakinumab with Docetaxel in NSCLC: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The Record History now shows a new revision entry Revision: v3.3.2 and the older Revision: v3.2.0 entry is removed. This update affects only the history metadata of the page, not the core trial information.
    Difference
    0.0%
    Check dated 2025-11-25T14:15:33.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-11-18T07:23:58.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Version 74 (posted 2023-08-16) updates the Study Status and Adverse Events sections. It also notes that Quality Control Review has not concluded.
    Difference
    0.0%
    Check dated 2025-10-27T20:51:56.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Major change: page now advertises a government operating status notice and updates the release version to v3.2.0; previous v3.1.0 label was removed.
    Difference
    7%
    Check dated 2025-10-06T08:00:21.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content or data appears to be altered.
    Difference
    0.2%
    Check dated 2025-09-29T04:38:01.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Updated to Revision: v3.0.2 and removed the 'Back to Top' link; overall a minor update with no impact on core content or key data.
    Difference
    0.5%
    Check dated 2025-09-14T21:51:54.000Z thumbnail image

Stay in the know with updates to Canakinumab with Docetaxel in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.